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Lehigh Valley Health Network, Allentown, Pennsylvania

Background
• Lehigh Valley Hospital Health Network (LVHN), a non-profit tertiary
care facility in Allentown, Pennsylvania is a Level 1 accredited Bariatric
Surgery Center performing over 375 procedures annually.
• LVHN joined the American College of Surgeons National Surgical
Quality Improvement Program (ACSNSQIP) in May 2006.
• The Agency for Healthcare Research and Quality (AHRQ) estimates that
2 million patients are managed on Coumadin or other anticoagulants
yearly.  
• As the incidence of obesity in America continues to increase, the
number of patients undergoing weight loss procedures is concurrently
rising (16,000 surgeries performed annually in 1990 climbed to about
140,000 in 2005).
• Patients on chronic anticoagulant therapy who undergo bariatric
surgery represent a unique patient population.
• In our institution, the practice pattern had been to return patients to
their pre-operative anticoagulation regime at the time of discharge
following bariatric surgery.
• We evaluated patients on pre-operative anticoagulation undergoing
bariatric surgical procedures who developed hemorrhagic
complications.

Methods

• A retrospective chart review was performed on all LVHN bariatric surgery
cases entered into the American College of Surgeons Bariatric Surgery
Center Network (ACSBSCN) database from 4/1/2008-9/30/2011.
• Patients identified as being on pre-operative anticoagulation were
stratified according to type of surgery and indication for anticoagulation.
• Date of readmission, reason for readmission, and initial INR levels were
collected on those patients who were readmitted in less than 40 days
and diagnosed with post procedure hemorrhage.

Results

Discussion

• Patient population
			 – 1338 patients underwent bariatric surgery
					 • 43 were on Coumadin or Antiplatelet therapy

			 – 133 patients were readmitted
					 • 25 patients were diagnosed with post-operative hemorrhage
							 • 10 of 25 were patients on pre-op anticoagulation/antiplatelet therapy

Table 1. Hemorrhage Readmissions

All Patients
Non-Anticoagulated Patients
Coumadin/Antiplatelet Patients

Total
Patients

Total
Readmissions

Hemorrhage
Readmissions

% of Readmits due
to Hemorrhage

1338
1295
43

133 (9.9%)
123 (9.4%)
14 (32.6%)

25 (1.9%)
15 (1.2%)
10 (23.3%)

18.8%
12.2%
71.4%

Table 2. Summarization of Patients Readmitted With a Hemorrhagic Event
Type of Surgery
LGB
LRNY
LRNY
LRNY
LRNY
LRNY
LRNY
LRNY
LRNY
LRNY

Type of
Hemorrhage
AB wall hematoma
GI Bleed/Melena
GI Bleed/Melena
GI Bleed/Melena
Gi Bleed/Melena
GI Bleed/Ulcer
GI Bleed/Melena
GI Bleed/Melena
Hematuria
GI Bleed/Melena

# of Days Post-op

INR at
Presentation

Indication for
Anticoagulation

4
10
14
24
25
27
28
35
36
39

1.3 + LMWH*
6.4
7.7
5.6
4.2
3.4
7.7
4.3
11.7
Plavix/ASA

Prior DVTs
Atrial Flutter
Atrial Fibrillation
PE
Factor V Leiden
Prior DVT
Atrial Flutter
Atrial Fibrillation
Prior DVTs
CAD with Stents

LRNY = laparoscopic gastric Roux-n-y, LGB = laparoscopic gastric band
* Low Molecular Weight Heparin

This preliminary data is the first to demonstrate a clear trend of
post-operative coagulopathy following bariatric surgery in patients
on chronic pre-operative Coumadin or Antiplatelet therapy.

Our data demonstrated a baseline 9.9% readmission rate for our entire
population (n=1338). Of readmissions, 18.8% (n=25) were readmitted for
bleeding symptoms. In the Coumadin/Antiplatelet population (n=43), a baseline
readmission rate of 32.6% was observed. In 71.4% of these cases (n=10),
bleeding symptoms were the cause for re-presentation. Intra-luminal bleeding
pervaded as the most frequent expression of hemorrhage.
Most symptomatic patients presented greater than 10 days post-operatively
with a mean INR of 5.8. Possible explanations for coagulopathy include altered
drug metabolism or changed volume of distribution (after rapid weight loss),
altered vitamin K dynamics (absorption, intake, or storage), peri-operative
medication interactions, and altered dietary intake etc. Patients presenting
earlier post-operatively with, an immediate increase in INR could represent a
drug-drug interaction or dietary factors while a delayed jump in the INR could
fit with depleted vitamin K stores that are being under-replaced.

Summary

• We identified a trend toward post-operative coagulopathy as captured by
readmission rate.
• There is no defined explanation for the development of post-operative
coagulopathy in this population. Potential causes are drug interaction, diet
modification, body habitus change.
• These hypotheses have not been tested. The investigators have initiated a
follow-up study to acquire data to this purpose.

Conclusion

• Based on our preliminary findings, we recommend discharging patients
on decreased Coumadin dose, checking INR within 48-72 hours
of discharge, and vigilant INR monitoring for several weeks postoperatively.

